Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Tang, Chao-Hsiun

Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort. [electronic resource] - Journal of the American Heart Association Jan 2016

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

2047-9980

10.1161/JAHA.115.002584 doi


Adrenergic beta-Antagonists--adverse effects
Adult
Aged
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Bisoprolol--adverse effects
Carbazoles--adverse effects
Carvedilol
Chi-Square Distribution
Databases, Factual
Delayed-Action Preparations
Drug Compounding
Female
Heart Failure--diagnosis
Humans
Kaplan-Meier Estimate
Kidney Failure, Chronic--diagnosis
Male
Metoprolol--adverse effects
Middle Aged
Multivariate Analysis
Propanolamines--adverse effects
Propensity Score
Proportional Hazards Models
Renal Dialysis--adverse effects
Retrospective Studies
Risk Factors
Taiwan
Time Factors
Treatment Outcome